PDE5 inhibitors (Hangzhou Adamerck)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePDE5 inhibitors (Hangzhou Adamerck)
Drug Alias NameAom-0891Aom-0890
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Adamerck Pharmlabs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Adamerck Pharmlabs Inc
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A